229 related articles for article (PubMed ID: 33953586)
41. Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats
Ying Y; Zhang H; Yu D; Zhang W; Zhou D; Liu S
Evid Based Complement Alternat Med; 2021; 2021():6659445. PubMed ID: 33643422
[TBL] [Abstract][Full Text] [Related]
42. [Mechanism of Calculus Bovis Sativus in inhibiting hepatocyte lipid deposition based on serum pharmacology].
He WX; Zhang CL; Xiang D; Yang JY; Xu YJ; Ren XH; Liu D
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3780-3785. PubMed ID: 31602953
[TBL] [Abstract][Full Text] [Related]
43. Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice.
Yang Y; Zhang W; Wu X; Wu J; Sun C; Luo F; Pei Z
Can J Gastroenterol Hepatol; 2021; 2021():8894685. PubMed ID: 33542911
[TBL] [Abstract][Full Text] [Related]
44. [Protective effects of deep sea water against subacute alcoholic liver injury].
Yue Q; Pan X; Liu Y; Chen T; Zhang L; Wang R
Wei Sheng Yan Jiu; 2018 Sep; 47(5):798-803. PubMed ID: 30593309
[TBL] [Abstract][Full Text] [Related]
45. Study on the protection of water extracts of Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata against NAFLD and its mechanism.
Lin L; Hao Z; Zhang S; Shi L; Lu B; Xu H; Ji L
J Ethnopharmacol; 2020 Apr; 252():112577. PubMed ID: 31953200
[TBL] [Abstract][Full Text] [Related]
46. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.
Liu B; Zhang J; Sun P; Yi R; Han X; Zhao X
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480575
[TBL] [Abstract][Full Text] [Related]
47. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
48. Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases.
Xing H; Jia K; He J; Shi C; Fang M; Song L; Zhang P; Zhao Y; Fu J; Li S
PLoS One; 2015; 10(6):e0128253. PubMed ID: 26030870
[TBL] [Abstract][Full Text] [Related]
49. Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.
Sun B; Rui R; Pan H; Zhang L; Wang X
Med Sci Monit; 2018 Sep; 24():6229-6236. PubMed ID: 30190450
[TBL] [Abstract][Full Text] [Related]
50. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis.
Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L
J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609
[TBL] [Abstract][Full Text] [Related]
51. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
52. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
Zhou X; Wang LL; Tang WJ; Tang B
J Ethnopharmacol; 2021 Mar; 268():113556. PubMed ID: 33157223
[TBL] [Abstract][Full Text] [Related]
53. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
54. Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway.
Liu YL; Zhang QZ; Wang YR; Fu LN; Han JS; Zhang J; Wang BM
Front Pharmacol; 2020; 11():605064. PubMed ID: 33708118
[No Abstract] [Full Text] [Related]
55. [Effects of sera of rats fed with
Yang M; Chen Z; Xiao C; Tang W; Zhou B
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1277-1287. PubMed ID: 30514673
[TBL] [Abstract][Full Text] [Related]
56. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
[TBL] [Abstract][Full Text] [Related]
57. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
58. Effect of Anoectochilus roxburghii flavonoids extract on H
Wang L; Chen Q; Zhuang S; Wen Y; Cheng W; Zeng Z; Jiang T; Tang C
J Ethnopharmacol; 2020 May; 254():112670. PubMed ID: 32135242
[TBL] [Abstract][Full Text] [Related]
59. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
60. Kinsenoside Alleviates Alcoholic Liver Injury by Reducing Oxidative Stress, Inhibiting Endoplasmic Reticulum Stress, and Regulating AMPK-Dependent Autophagy.
Gao L; Chen X; Fu Z; Yin J; Wang Y; Sun W; Ren H; Zhang Y
Front Pharmacol; 2021; 12():747325. PubMed ID: 35115920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
